High degrees of insulin resistance in women may increase their rates of pregnancy and birth complications.
High degrees of insulin resistance in women may increase their rates of pregnancy complications and birth complications, and testing pregnant women for insulin resistance may be a useful way to predict problems, according to study findings presented at the Endocrine Society's 90th Annual Meeting, held June 15–18 in San Francisco.
Weerapan Khovidhunkit, MD, PhD, of Chulalongkorn University in Bangkok, Thailand, and colleagues studied 538 pregnant women who had a positive glucose challenge test, and then underwent an oral glucose tolerance test. The researchers also used homeostatic model assessment to assess insulin resistance, and tracked pregnancy complications including preeclampsia, polyhydramnios, premature rupture of membranes, and cesarean section delivery.
Women with the highest degree of insulin resistance (>2.44) had a rate of pregnancy complications nearly 1.5 times greater than those with the lowest insulin resistance, regardless of the presence of gestational diabetes, the researchers found. Babies born to women in the group with the highest insulin resistance had a complication rate at birth that was nearly 1.75 times higher than babies born to women in the lowest insulin resistance group. The most common maternal complication was need for a C/S, and the most common infant complications were macrosomia and hypoglycemia.
More information on the research is available at http://endo-society.org/.
Daré Bioscience initiates phase 3 clinical trial for ovaprene contraceptive
December 5th 2023Daré Bioscience has commenced a pivotal phase 3 clinical trial for ovaprene, an intravaginal contraceptive that releases a locally acting agent to prevent sperm entry into the cervical canal, marking a significant step towards a non-hormonal contraceptive option for women.
Read More
Exploring menstrual health: Insights from the Avon longitudinal study
December 5th 2023Unveiling a comprehensive analysis of menstrual cycle characteristics in mothers and daughters, this article delves into the diverse features, potential risk factors, and the importance of understanding these nuances for effective menstrual health management.
Read More
Integrating pharmacists into PPHTN management for enhanced blood pressure control
December 4th 2023A study reveals that involving pharmacists in the care of postpartum women at risk of persistently elevated blood pressure, as presented at the American Society of Health-System Pharmacists 2023 Midyear Clinical Meeting and Exhibition, can provide an effective and feasible solution to managing hypertensive disorders, reducing postpartum readmission risks, and improving overall health care access.
Read More